Resistance to Antimicrobial Peptides and Stress Response in Mycoplasma pulmonis
Authors:
Open Access
- 1 October 2005
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 49 (10) , 4154-4165
Abstract
Antimicrobial peptides are widely distributed in nature, and in vertebrates, they play a key function in the innate immune defense system. It is generally agreed that these molecules may provide new antibiotics with therapeutic value. However, there are still many unsolved questions regarding the mechanisms underlying their antimicrobial activity as well as the mechanisms of resistance evolved by microorganisms against these molecules. The second point was addressed in this study. After determining the activity of 10 antimicrobial peptides against Mycoplasma pulmonis , a murine respiratory pathogen, the development of resistance was investigated. Following in vitro selection using subinhibitory concentrations of peptides, clones of this bacterium showing increased resistance to melittin or gramicidin D were obtained. For some of the clones, a cross-resistance was observed between these two peptides, in spite of their deep structural differences, and also with tetracycline. A proteomic analysis suggested that the stress response in these clones was constitutively activated, and this was confirmed by finding mutations in the hrcA gene; in mycoplasmas, bacteria which lack alternative sigma factors, the HrcA protein is supposed to play a key role as a negative regulator of heat shock proteins. By complementation of the hrcA mutants with the wild-type gene, the initial MICs of melittin and gramicidin D decreased to values close to the initial ones. This indicates that the resistance of M. pulmonis to these two antimicrobial peptides could result from a stress response involving HrcA-regulated genes.Keywords
This publication has 57 references indexed in Scilit:
- Capsule Polysaccharide Mediates Bacterial Resistance to Antimicrobial PeptidesInfection and Immunity, 2004
- Resistance ofMycoplasma pulmonisto Complement Lysis Is Dependent on the Number of Vsa Tandem Repeats: Shield HypothesisInfection and Immunity, 2004
- Crystal Structure ofEscherichia coliArnA (PmrI) Decarboxylase Domain. A Key Enzyme for Lipid A Modification with 4-Amino-4-deoxy-l-arabinose and Polymyxin Resistance,Biochemistry, 2004
- Identification of the Origin of Replication of the Mycoplasma pulmonis Chromosome and Its Use in oriC Replicative PlasmidsJournal of Bacteriology, 2002
- Susceptibilities of Mycoplasma fermentans and Mycoplasma hyorhinis to Membrane-Active Peptides and Enrofloxacin in Human Tissue Cell CulturesAntimicrobial Agents and Chemotherapy, 2002
- Mutator Bacteria as a Risk Factor in Treatment of Infectious DiseasesAntimicrobial Agents and Chemotherapy, 2002
- Osmotic Stress in ViableEscherichia colias the Basis for the Antibiotic Response by Polymyxin BBiochemical and Biophysical Research Communications, 1998
- Cationic peptides: a new source of antibioticsTrends in Biotechnology, 1998
- CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choiceNucleic Acids Research, 1994
- Prevalence of Mycoplasma pneumoniae in Subjectively Healthy Individuals1Scandinavian Journal of Infectious Diseases, 1992